Skip to Main Content

Author Details

Shilpa Bhatia
University of Colorado Denver at Anschutz Medical Campus
2011
45
18
PMIDPaper TitleJournal TitlePublished Year
36577897Author Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.Nat Cancer2023
36990508Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment.J Immunother Cancer2023
34559306Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma.Cancer Immunol Immunother2022
35725568EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment.Nat Commun2022
36434392A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC.Nat Cancer2022
34862244Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma.Clin Cancer Res2022
34793974Dichotomous effects of cellular expression of STAT3 on tumor growth of HNSCC.Mol Ther2022
33097963Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.Cancer Immunol Immunother2021
33883256Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.J Immunother Cancer2021
33789881Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer.J Immunother Cancer2021
33526513Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer.Cancer Res2021
34518311FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC.Clin Cancer Res2021
32567728The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme.Mol Carcinog2020
31058896Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment.J Vis Exp2019
30894369Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers.Cancer Res2019
30863843STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer.J Natl Cancer Inst2019
30944125Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination.Clin Cancer Res2019
29774792Hypofractionated Radiotherapy Is Superior to Conventional Fractionation in an Orthotopic Model of Anaplastic Thyroid Cancer.Thyroid2018
29970482Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor.Mol Cancer Ther2018
30042205Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration.Clin Cancer Res2018
29848571Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers.Clin Cancer Res2018
27649287Ephrin-B2 overexpression predicts for poor prognosis and response to therapy in solid tumors.Mol Carcinog2017
28360821Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma.Cancer Cell Int2017
29123967Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma.Oncoimmunology2017
27727461A comparison of overall survival for patients with T4 larynx cancer treated with surgical versus organ-preservation approaches: A National Cancer Data Base analysis.Cancer2017
27086480Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base.Oral Oncol2016
27957479CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter.Oncolytic Virother2016
27941840Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas.Sci Rep2016
25196387Gene Therapies for Cancer: Strategies, Challenges and Successes.J Cell Physiol2015
26345456Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model.J Hematol Oncol2015
26697450The radiobiological targets of SBRT: tumor cells or endothelial cells?Ann Transl Med2015
26142027Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?Pract Radiat Oncol2015
25879388Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization.Oncotarget2015
24502370Non-BRAF targeted therapies for melanoma: protein kinase inhibitors in Phase II clinical trials.Expert Opin Investig Drugs2014
25497053Refractory trigeminal neuralgia treatment outcomes following CyberKnife radiosurgery.Radiat Oncol2014
25593999MDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinoma.Oncoscience2014
25340041Stereotactic body radiotherapy as primary therapy for head and neck cancer in the elderly or patients with poor performance.Front Oncol2014
25374840IMRT with Stereotactic Body Radiotherapy Boost for High Risk Malignant Salivary Gland Malignancies: A Case Series.Front Oncol2014
25001534MDA-7/IL-24: multifunctional cancer killing cytokine.Adv Exp Med Biol2014
23725604Innovative approaches for enhancing cancer gene therapy.Discov Med2013
23873690Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling.Clin Cancer Res2013
22723923PET imaging a MPTP-induced mouse model of Parkinson's disease using the fluoropropyl-dihydrotetrabenazine analog [18F]-DTBZ (AV-133).PLoS One2012
23056548Dendritic cell based PSMA immunotherapy for prostate cancer using a CD40-targeted adenovirus vector.PLoS One2012
21347423Genetic incorporation of human metallothionein into the adenovirus protein IX for non-invasive SPECT imaging.PLoS One2011
21893382Establishment of a mammary carcinoma cell line from Syrian hamsters treated with N-methyl-N-nitrosourea.Cancer Lett2011
  • 1 - 45 of 45

Recommended Authors

Hua Li
University of California san francisco
Career Start Year 2013
Number of shared co-authors 3
Toni M Brand
University of Wisconsin School of Medicine and Public Health
Career Start Year 2011
Number of shared co-authors 0
Juan L Callejas-Valera
Cancer Biology Research Center
Career Start Year 2008
Number of shared co-authors 1
Zhiyong Wang
Moores Cancer Center, University of California San Diego
Career Start Year 2008
Number of shared co-authors 1
Julie E Bauman
George Washington University
Career Start Year 2007
Number of shared co-authors 3
Neil E Bhola
Zai Lab (US) LLC
Career Start Year 2006
Number of shared co-authors 2
Sophia Bornstein
Cornell University
Career Start Year 2005
Number of shared co-authors 2
Jalna Meens
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 0
Wei Shi
Research Institute, Princess Margaret Cancer Centre
Career Start Year 2002
Number of shared co-authors 2
Ezra E W Cohen
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 4
Daniel Zingg
Netherlands Cancer Institute
Career Start Year 2001
Number of shared co-authors 0
Christopher D Willey
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 1
Eddy S Yang
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 0
Richard J Wong
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Marc Vooijs
Maastricht University Medical Centre+
Career Start Year 1997
Number of shared co-authors 0
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Career Start Year 1996
Number of shared co-authors 1
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Career Start Year 1996
Number of shared co-authors 0
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Career Start Year 1996
Number of shared co-authors 1
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 2
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 2
Kevin Camphausen
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Frank B Furnari
University of California San Diego
Career Start Year 1992
Number of shared co-authors 2
Donald M O'Rourke
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Career Start Year 1991
Number of shared co-authors 1
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 2
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 2
Jennifer R Grandis
University of California san francisco
Career Start Year 1988
Number of shared co-authors 4
Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 1
William A Weiss
University of California san francisco
Career Start Year 1985
Number of shared co-authors 2
Carter Van Waes
National Institute of Deafness and Other Communication Disorders
Career Start Year 1984
Number of shared co-authors 2

Collaborators

Sana D Karam
University of Colorado School of Medicine
Co-authored papers 33
Ayman Oweida
Universite de Sherbrooke
Co-authored papers 19
Benjamin Van Court
University of Colorado
Co-authored papers 17
Laurel B Darragh
University of Colorado Denver at Anschutz Medical Campus
Co-authored papers 16
Andy Phan
University of Colorado Anschutz Medical Campus
Co-authored papers 10
Antonio Jimeno
University of Colorado School of Medicine
Co-authored papers 8
Adam C Mueller
Sidney Kimmel Cancer Center at Thomas Jefferson University
Co-authored papers 8
Thomas E Bickett
University of Colorado
Co-authored papers 7
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Co-authored papers 5
Elena B Pasquale
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 4
Wells A Messersmith
University of Colorado Anschutz Medical Campus
Co-authored papers 4
Richard D Schulick
University of Colorado School of Medicine
Co-authored papers 4
Karyn A Goodman
Mount Sinai Hospital
Co-authored papers 4
Marco Del Chiaro
University of Colorado
Co-authored papers 3
Jason Williams
University of Colorado Denver
Co-authored papers 3
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Kirk C Hansen
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Michael J Gough
Earle A. Chiles Research Institute, Providence Cancer Institute
Co-authored papers 2
Angelo D'Alessandro
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Sujatha Venkataraman
Co-authored papers 2
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Co-authored papers 2
Stephen B Keysar
University of Colorado Denver
Co-authored papers 2
Rajeev Vibhakar
Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Co-authored papers 2
Gregory N Gan
Co-authored papers 1
Michael W Knitz
University of Colorado
Co-authored papers 1
Brian R Rood
Brain Tumor Institute, Children's National Hospital
Co-authored papers 1
Dean A Troyer
Eastern Virginia Medical School
Co-authored papers 1
Cheryl Meguid
University of Colorado
Co-authored papers 1
David Lagares
Fibrosis Research Center, Massachusetts General Hospital, Harvard Medical School
Co-authored papers 1
Joseph A Califano
University of California
Co-authored papers 1
Release 1.2